All Episodes

Gastroesophageal Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers

Chronic Lymphocytic Leukemia | Jeff Sharman, MD

Chronic Lymphocytic Leukemia | Lindsey Roeker, MD

Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Hepatobiliary Cancers | Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers

Prostate Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series

Colorectal Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer

Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer

Gastroesophageal Cancers | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers

Hormone Receptor-Positive Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer

Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO

Hormone Receptor-Positive Breast Cancer | Stephanie L Graff, MD, FACP

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma

Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma

HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer

Chronic Lymphocytic Leukemia | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia

HER2-Negative Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer

Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma

ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer

Gynecologic Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Biliary Tract Cancer | Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers

Biliary Tract Cancer | Milind Javle, MD

Biliary Tract Cancer | Lipika Goyal, MD, MPhil

Lung Cancer | Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

Non-Small Cell Lung Cancer | Aaron Lisberg, MD

Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD

Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Breast Cancer | Implications of Recent Data Sets for the Current and Future Management of Breast Cancer

Gynecologic Cancers | Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series

HER2-Positive and Triple-Negative Breast Cancer | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Multiple Myeloma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Gynecologic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Hepatobiliary and Pancreatic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Urothelial Bladder Cancer and Renal Cell Carcinoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Lymphoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

Chronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Colorectal and Gastroesophageal Cancers | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Non-Small Cell Lung Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Prostate Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

ER-Positive Breast Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Diffuse Large B-Cell Lymphoma | Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma

Nonmelanoma Skin Cancer | Nikhil I Khushalani, MD

Nonmelanoma Skin Cancer | Anna C Pavlick, DO, MBA

Nonmelanoma Skin Cancer | Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series

Mantle Cell Lymphoma | What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences

Lung Cancer | John V Heymach, MD, PhD

Lung Cancer | Jamie E Chaft, MD

Lung Cancer | Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Colorectal Cancer | Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer

Colorectal Cancer | J Randolph Hecht, MD

Colorectal Cancer | Kristen K Ciombor, MD, MSCI

Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm (Companion Faculty Lecture)

Myelofibrosis | Consensus or Controversy? Documenting and Discussing Clinical Investigators' Practice Patterns in Myelofibrosis

Breast Cancer | Hope S Rugo, MD

Breast Cancer | Tiffany A Traina, MD, FASCO

Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma (Companion Faculty Lecture)

Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer

Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)

Hematologic Oncology | What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

Pancreatic Cancer | Zev Wainberg, MD, MSc

Pancreatic Cancer | Eileen M O'Reilly, MD

Pancreatic Cancer | Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer

Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhD

Non-Hodgkin Lymphoma | Loretta J Nastoupil, MD

Non-Hodgkin Lymphoma | Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Melanoma | Meet The Professor: Optimizing the Management of Melanoma

Lung Cancer | Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

Hepatocellular Carcinoma | The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Prostate Cancer | Neal D Shore, MD

Prostate Cancer | Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma

Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma (Companion Faculty Lecture)

Soft Tissue Sarcoma | Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series

Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences

Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences (Companion Faculty Lecture)

Genitourinary Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

Breast Cancer | Erika Hamilton, MD

Breast Cancer | Aditya Bardia, MD, MPH

Multiple Myeloma | Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management

Multiple Myeloma | Hans Lee, MD

Multiple Myeloma | Saad Zafar Usmani, MD, MBA